Gene · 2201
Papers2,084
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,084
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ex vivo exposures to arsenite and its methylated trivalent metabolites alter gene transcription in mouse sperm cells. | Toxicol Appl Pharmacol | 2022 | 36209798 | PubTator, text mining | PubMed |
| A whole genome sequencing approach to anterior cruciate ligament rupture-a twin study in two unrelated families. | PLoS One | 2022 | 36201451 | PubTator, text mining | PubMed |
| Identification of a HOXD13 variant in a Mongolian family with incomplete penetrance syndactyly by exon sequencing. | BMC Med Genomics | 2022 | 36195906 | PubTator, text mining | PubMed |
| Aortic Cellular Diversity and Quantitative Genome-Wide Association Study Trait Prioritization Through Single-Nuclear RNA Sequencing of the Aneurysmal Human Aorta. | Arterioscler Thromb Vasc Biol | 2022 | 36172868 | PubTator, text mining | PubMed |
| A comprehensive role evaluation and mechanism exploration of POGLUT2 in pan-cancer. | Front Oncol | 2022 | 36158688 | PubTator, text mining | PubMed |
| Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19. | Front Endocrinol (Lausanne) | 2022 | 36157452 | PubTator, text mining | PubMed |
| Reliable assessment of telomere maintenance mechanisms in neuroblastoma. | Cell Biosci | 2022 | 36153564 | PubTator, text mining | PubMed |
| The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma. | Front Immunol | 2022 | 36131921 | PubTator, text mining | PubMed |
| Human intestinal myofibroblasts deposited collagen VI enhances adhesiveness for T cells - A novel mechanism for maintenance of intestinal inflammation. | Matrix Biol | 2022 | 36108990 | PubTator, text mining | PubMed |
| Exploring the multidimensional heterogeneities of glioblastoma multiforme based on sample-specific edge perturbation in gene interaction network. | Front Immunol | 2022 | 36105808 | PubTator, text mining | PubMed |
| Advances on the roles of tenascin-C in cancer. | J Cell Sci | 2022 | 36102918 | PubTator, text mining | PubMed |
| Identification of ACSL4 as a biomarker and contributor of ferroptosis in clear cell renal cell carcinoma. | Transl Cancer Res | 2022 | 36093519 | PubTator, text mining | PubMed |
| Identification of lactate metabolism-related subtypes and development of a lactate-related prognostic indicator of lung adenocarcinoma. | Front Genet | 2022 | 36092870 | PubTator, text mining | PubMed |
| Natural history of type 1 diabetes on an immunodysregulatory background with genetic alteration in B-cell activating factor receptor: A case report. | Front Immunol | 2022 | 36090979 | PubTator, text mining | PubMed |
| 3D tissue-engineered lung models to study immune responses following viral infections of the small airways. | Stem Cell Res Ther | 2022 | 36071442 | PubTator, text mining | PubMed |
| Integrated cohort of esophageal squamous cell cancer reveals genomic features underlying clinical characteristics. | Nat Commun | 2022 | 36071046 | PubTator, text mining | PubMed |
| A TNNI2 variant c.525G>T causes distal arthrogryposis in a Chinese family. | Mol Genet Genomic Med | 2022 | 36069346 | PubTator, text mining | PubMed |
| Pooled resequencing of larvae and adults reveals genomic variations associated with Ostreid herpesvirus 1 resistance in the Pacific oyster Crassostrea gigas. | Front Immunol | 2022 | 36059443 | PubTator, text mining | PubMed |
| Challenges and perspectives of tendon-derived cell therapy for tendinopathy: from bench to bedside. | Stem Cell Res Ther | 2022 | 36056395 | PubTator, text mining | PubMed |
| Circulating microRNA: Myocardium-derived prenatal biomarker of ventricular septal defects. | Front Genet | 2022 | 36035156 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2201/papers?page=17